Romiset 250 mcg Injection Substitute

Romiset 250 mcg Injection belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.

Romiset 250 mcg Injection contains Romiplostim, which promotes platelet formation by activating the thrombopoietin receptor. Thus Romiset 250 mcg Injection lowers the risk of bleeding episodes in diseases like immune thrombocytopenia and other associated conditions.

Immune thrombocytopenia is an autoimmune disorder in which the immune system misidentifies platelets as foreign bodies and destroys them. It can occur due to a virus, vaccination, or certain drugs. But the origin is unknown in the majority of cases.

Romiset 250 mcg Injection is only advised for patients who have not responded adequately to other treatments such as corticosteroids, immunoglobulins, or splenectomy.

Idiopathic thrombocytopenic purpura is typically diagnosed with blood tests such as complete blood count and antiplatelet-antibody test.